Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 7 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 10626111

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  2. US 10597384

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  3. US 10570115

    Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  4. US 10537565

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  5. US 10501439

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  6. US 10479784

    Substituted pyrazin-2-amines as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  7. US 10478430

    Compounds useful as inhibitors of ATR kinase and combination therapies thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  8. US 10442791

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  9. US 10407414

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  10. US 10391095

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  11. US 10392391

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  12. US 10385070

    Chroman-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  13. US 10301304

    Selective inhibitor of phosphatidylinositol 3-kinase-gamma

    Vertex Pharmaceuticals Incorporated · Granted May 28, 2019 · Expires May 23, 2039

    granted

  14. US 10302602

    Process of conducting high throughput testing high performance liquid chromatography

    Vertex Pharmaceuticals Incorporated · Granted May 28, 2019 · Expires May 23, 2039

    granted

  15. US 10272046

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  16. US 10273233

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  17. US 10258624

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  18. US 10258627

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  19. US 10253054

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  20. US 10239867

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  21. US 10233191

    Fused piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  22. US 10231932

    Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  23. US 10206877

    Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  24. US 10183933

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.